Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Cancer
|
April 1, 1990
Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children
T T Tang, A D Segura, H W Oechler, et al.
American Journal of Clinical Pathology
|
January 1, 1986
Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy
T T Tang, J M Harb, W M Dunne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Prognostic factors in childhood acute myelogenous leukemia
H E Grier, R D Gelber, B M Camitta, et al.
Bone Marrow Transplantation
|
November 8, 2005
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL
J M Talano, J T Casper, B M Camitta, et al.
Leukemia
|
July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial
S J Lauer, J J Shuster, D H Mahoney, et al.
Blood
|
March 1, 1979
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
B M Camitta, E D Thomas, D G Nathan, et al.
Journal of Pediatric Hematology/Oncology
|
June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study
S J Lauer, B M Camitta, B G Leventhal, et al.
Blood
|
September 26, 2000
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases
N R Schneider, A J Carroll, J J Shuster, et al.
Cancer
|
May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study
D H Mahoney, B M Camitta, B G Leventhal, et al.
Blood
|
February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study
J E Rubnitz, J J Shuster, V J Land, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Cancer
|
April 1, 1990
Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children
T T Tang, A D Segura, H W Oechler, et al.
American Journal of Clinical Pathology
|
January 1, 1986
Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy
T T Tang, J M Harb, W M Dunne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Prognostic factors in childhood acute myelogenous leukemia
H E Grier, R D Gelber, B M Camitta, et al.
Bone Marrow Transplantation
|
November 8, 2005
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL
J M Talano, J T Casper, B M Camitta, et al.
Leukemia
|
July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial
S J Lauer, J J Shuster, D H Mahoney, et al.
Blood
|
March 1, 1979
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
B M Camitta, E D Thomas, D G Nathan, et al.
Journal of Pediatric Hematology/Oncology
|
June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study
S J Lauer, B M Camitta, B G Leventhal, et al.
Blood
|
September 26, 2000
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases
N R Schneider, A J Carroll, J J Shuster, et al.
Cancer
|
May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study
D H Mahoney, B M Camitta, B G Leventhal, et al.
Blood
|
February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study
J E Rubnitz, J J Shuster, V J Land, et al.
Page
of 12